Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity (Deficit)

v3.19.3
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Subscriptions Receivable [Member]
Subscriptions Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Mar. 26, 2018
Balance, shares at Mar. 26, 2018              
Consolidation of One World Pharma, Inc. (349,420) (349,420)
Common stock sold for cash $ 23,412 978,703 (602) 1,001,513
Common stock sold for cash, shares 23,411,905              
Common stock issued for services $ 680 284,920 285,600
Common stock issued for services, shares 680,000              
Common stock issued for purchase of One World Pharma S.A.S. $ 10,200 152,709 162,909
Common stock issued for purchase of One World Pharma S.A.S., shares 10,200,000              
Contributed capital 136,440 136,440
Beneficial conversion feature on convertible note 75,000 75,000
Gain (loss) on foreign currency translation (4,090) (4,090)
Net loss   (1,959,982) (101) (1,960,083)
Balance at Dec. 31, 2018 $ 34,292 1,278,352 (602) (4,090) (1,959,982) (101) (652,131)
Balance, shares at Dec. 31, 2018 34,291,905              
Common stock sold for cash $ 3,900 1,946,100 1,950,000
Common stock sold for cash, shares 3,900,000              
Common stock issued for services $ 30 14,970 15,000
Common stock issued for services, shares 30,000              
Beneficial conversion feature on convertible note   125,000           125,000
Gain (loss) on foreign currency translation         (8,287)     (8,287)
Cash received on subscriptions receivable 602 602
Issuance of common stock on debt conversions $ 1,253 500,144 501,397
Issuance of common stock on debt conversions, shares 1,253,493              
Amortization of common stock options issued for services, OWP Ventures, Inc. 88,297 88,297
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1) $ 1,323 (10,730) 101 (9,306)
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1), shares 1,322,501              
Common stock cancelled pursuant to merger with OWP Ventures, Inc. $ (875) 875
Common stock cancelled pursuant to merger with OWP Ventures, Inc., shares (875,000)              
Amortization of common stock options issued for services 165,243 165,243
Net loss (1,323,516) (1,323,516)
Balance at Mar. 31, 2019 $ 39,923 4,108,251 (12,377) (3,283,498) 852,299
Balance, shares at Mar. 31, 2019 39,922,899              
Balance at Dec. 31, 2018 $ 34,292 1,278,352 (602) (4,090) (1,959,982) (101) (652,131)
Balance, shares at Dec. 31, 2018 34,291,905              
Gain (loss) on foreign currency translation               (21,121)
Net loss               (4,445,726)
Balance at Sep. 30, 2019 $ 44,483 7,391,508 160,000 (25,211) (6,405,708) 1,165,072
Balance, shares at Sep. 30, 2019 44,482,939              
Balance at Mar. 31, 2019 $ 39,923 4,108,251 (12,377) (3,283,498) 852,299
Balance, shares at Mar. 31, 2019 39,922,899              
Gain (loss) on foreign currency translation 151,288 151,288
Amortization of common stock options issued for services 395,715 395,715
Net loss (1,325,228) (1,325,228)
Balance at Jun. 30, 2019 $ 39,923 4,503,966 138,911 (4,608,726) 74,074
Balance, shares at Jun. 30, 2019 39,922,899              
Common stock sold for cash $ 4,509 2,249,991 2,254,500
Common stock sold for cash, shares 4,509,000              
Beneficial conversion feature on convertible note 207,332 207,332
Gain (loss) on foreign currency translation (164,122) (164,122)
Amortization of common stock options issued for services 430,270 430,270
Common stock payable for services 160,000 160,000
Cashless exercise of common stock options $ 51 (51)
Cashless exercise of common stock options, shares 51,040              
Net loss (1,796,982) (1,796,982)
Balance at Sep. 30, 2019 $ 44,483 $ 7,391,508 $ 160,000 $ (25,211) $ (6,405,708) $ 1,165,072
Balance, shares at Sep. 30, 2019 44,482,939